GLSI
Greenwich Lifesciences Inc
15.40$
-2.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | -100.0% | – | |
| – | – | – | +0.0% | +0.0% | – | – | -3.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +8.1% | -5.9% | +5.2% | -0.7% | +168.7% | -63.1% | +54.5% | +0.4% | +115.5% | -31.4% | -31.7% | – | |
| – | +45.9% | -31.9% | +3.2% | +23.6% | +340.8% | -64.6% | -21.0% | +21.4% | -45.6% | +45.9% | -10.7% | – | |
| – | +13.3% | -10.6% | +4.9% | +2.5% | +196.3% | -65.8% | +46.1% | +3.2% | +90.3% | -27.9% | -29.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.